We are live on ! Find out more
MRNA

MARINA BIOTECH INC COM STK (DE)
MRNA

Delisted

MRNA was delisted on the 1st of February, 2012.

Back to rankings

2 hedge funds and large institutions have $30.7K invested in MARINA BIOTECH INC COM STK (DE) in 2026 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more capital invested

Capital invested by funds: $27.3K → $30.7K (+$3.34K)

0% more funds holding

Funds holding: 2 → 2 (0)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BAM
Byrne Asset Management
New Jersey
-$7K

MRNA Hedge Fund Activity: Q2 2026 in Review

2 of the 8,334 institutional investors tracked by Wall St. Rank reported a position in MARINA BIOTECH INC COM STK (DE) (MRNA) for Q2 2026, worth a combined $30.7K — up 12% from $27.3K a quarter earlier.

Fund positioning in MRNA was balanced in Q2 2026: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.

The largest seller was Byrne Asset Management, cutting an estimated $7K.

  • 2 institutional investors held MARINA BIOTECH INC COM STK (DE) (MRNA) as of Q2 2026, unchanged from Q1 2026.
  • Funds reported $30.7K of MARINA BIOTECH INC COM STK (DE) stock for Q2 2026, up 12% quarter-over-quarter.
  • 0 funds opened new MARINA BIOTECH INC COM STK (DE) positions in Q2 2026 and 0 closed out.
  • The largest MARINA BIOTECH INC COM STK (DE) seller in Q2 2026 was Byrne Asset Management, an estimated $7K sold.

Based on aggregated 13F filings for Q2 2026.